论文部分内容阅读
应用形态学标准与免疫组织化学方法对１００例非霍奇金淋巴瘤（ＮＨＬ）的分类与预后关系进行了研究。在ＮＨＬ中，细胞分类的百分率如下：Ｂ细胞６６％，Ｔ细胞２９％，非Ｂ非Ｔ细胞２％，组织细胞３％。根据形态学的标准，Ｔ与Ｂ淋巴瘤的肿瘤细胞可被分别分为四与六种亚型。详细地描述了每种亚型的形态学特征。随访结果表明了Ｂ细胞淋巴后的预后比Ｔ细胞淋巴瘤好。淋巴瘤的正确分类有助于病人的治疗。作者建议对淋巴母细胞与中心母细胞类型的ＮＨＬ需要进行积极的化疗与放疗。
The relationship between classification and prognosis of 100 cases of non-Hodgkin lymphoma (NHL) was studied using morphological criteria and immunohistochemistry. The percentage of cell classification in NHL is as follows: 66% for B cells, 29% for T cells, 2% for non-B non-T cells, and 3% for tissue cells. According to the morphological criteria, T and B lymphoma tumor cells can be divided into four and six subtypes, respectively. The morphological characteristics of each subtype are described in detail. Follow-up results showed that the prognosis of B-cell lymphoma was better than that of T-cell lymphoma. The correct classification of lymphomas helps the patient’s treatment. The authors suggest that active chemotherapy and radiotherapy for lymphoblasts and central mother cell type NHL are required.